396 results on '"Hoogwerf, Byron J"'
Search Results
2. Results of a 24-Week Trial of Technosphere Insulin Versus Insulin Aspart in Type 2 Diabetes
3. Real-World Glycemic Lowering Effectiveness of Linagliptin Among Adults with Type 2 Diabetes by Age, Renal Function, and Race
4. Risk Factors for Nocturnal Hypoglycemia in Insulin-treated Patients With Type 2 Diabetes: A Secondary Analysis of Observational Data Derived From an Integrated Clinical Trial Database
5. Statins may increase diabetes, but benefit still outweighs risk
6. Prediabetes, Atrial Fibrillation, and Heart Failure: An Intersection of Comorbidities
7. Diabetes Mellitus, Hyperinsulinemia, and Coronary Artery Disease
8. Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study
9. Diabetes Mellitus, Hyperinsulinemia, and Coronary Artery Disease
10. Non‐alcoholic fatty liver disease (NAFLD) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes
11. Clinical Outcomes of Concomitant Therapy of Exenatide Twice Daily and Basal Insulin In Patients with Type 2 Diabetes Mellitus: A Retrospective Database Analysis In the United States
12. Efficacy of GLP-1 Receptor Agonists and DPP-4 Inhibitors: Meta-Analysis and Systematic Review
13. Use of Concomitant Glucose-Lowering Therapies and Associated Treatment Results Observed in Clinical Trials of Twice-Daily Exenatide
14. Renin–Angiotensin System Blockade and Cardiovascular and Renal Protection
15. Diabetes Mellitus in Women
16. Dietary Treatment of Lipids and Lipoprotein Disorders
17. Emerging Cardiovascular Risk Factors That Account for a Significant Portion of Attributable Mortality Risk in Chronic Kidney Disease
18. Glucagon-Like Peptide 1 Receptor Agonist or Bolus Insulin With Optimized Basal Insulin in Type 2 Diabetes
19. Frederick C. Goetz, MD: A Profile of the Intersection Among Science, the Fine Arts, and Education
20. Safety and Tolerability of Acarbose in the Treatment of Type 1 and Type 2 Diabetes Mellitus
21. Coronary artery bypass graft surgery and cognitive performance
22. Teambuilding and leadership training in an internal medicine residency training program: Experience with a one-day retreat
23. Heart rate and blood pressure responses to mental stress and clinical cardiovascular events in men and women after coronary artery bypass grafting: The post coronary artery bypass graft(Post-CABG) biobehavioral study
24. The Hemostatic Effects of Warfarin Titration in Post CABG Patients in Comparison to Placebo Treatment
25. Lipid-Lowering Strategies and Reduction of Coronary Heart Disease Risk
26. Diabetes Mellitus
27. Diabetes Mellitus—Overview
28. Use of Twice-Daily Exenatide in Basal Insulin–Treated Patients With Type 2 Diabetes: A Randomized, Controlled Trial
29. Risk of Cardiovascular Disease Events in Patients With Type 2 Diabetes Prescribed the Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Exenatide Twice Daily or Other Glucose-Lowering Therapies: A retrospective analysis of the LifeLink database
30. Understanding inhaled Technosphere Insulin: Results of an early randomized trial in type 1 diabetes mellitus
31. Hypoglycemia in Older Patients
32. 235-OR: Incidence of Significant Changes in Pulmonary Function during a 2-Year Study with Inhaled Technosphere Insulin
33. 1023-P: Dose Titration and Clinical Effects of Inhaled Technosphere Insulin Compared with Mealtime Subcutaneous (SC) Analog Insulin Therapy in Type 1 Diabetes (T1D)
34. 1024-P: Technosphere Insulin Added to Basal Insulin Is Associated with Less Weight Gain than Basal Insulin plus Insulin Aspart or Insulin Analog (Aspart) 70/30 Mixture in Type 2 DM
35. Effects of Cardiac Autonomic Dysfunction on Mortality Risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial
36. Association of SF-36 With Coronary Artery Disease Risk Factors and Mortality: A PreCIS Study
37. High school body mass index and body mass index at entry to a cardiac disease risk prevention clinic and the association to all-cause mortality and coronary heart disease a preCIS database study
38. Serum uric acid level reduction, cardiovascular outcome, and mortality: comment on the article by Ioachimescu et al
39. Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: A preventive cardiology information system (PreCIS) database cohort study
40. Advances in the Treatment of Diabetes Mellitus in the Elderly: Development of Insulin Analogues
41. The Effect of Adding Exenatide to a Thiazolidinedione in Suboptimally Controlled Type 2 Diabetes: A Randomized Trial
42. Serum Uric Acid Is an Independent Predictor of Mortality in Patients with Type 2 Diabetes Mellitus-A PreCIS Data Base Cohort Study: 914-P
43. HgbA1c and glucose control: We cannot play it straight with patients
44. Quality of Life After Coronary Artery Bypass Graft: Results From the POST CABG Trial
45. Elevated international normalized ratio in the ED: clinical course and physician adherence to the published recommendations
46. Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: Results of the HOPE Study
47. Association of dyslipidemia and effects of statins on nonmacrovascular diseases
48. Association of Triglyceride-to-HDL Cholesterol Ratio With Heart Rate Recovery
49. How I treat dyslipidemia in diabetes mellitus
50. Heart rate and blood pressure responses to mental stress and clinical cardiovascular events in men and women after coronary artery bypass grafting: The Post Coronary Artery Bypass Graft (Post-CABG) biobehavioral study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.